一个关于新兴的药理疗法对梅博米腺功能障碍的更新
Giulia Coco1, Giuseppe Giannaccare2
1Ophthalmology, Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy.
Expert opinion on pharmacotherapy
|January 4, 2025
概括
梅博米腺功能障碍 (MGD) 的新疗法正在出现,梅博米腺功能障碍 (MGD) 是干眼疾病 (DED) 的常见原因. 这些疗法针对MGD.
科学领域:
- 眼科医生 眼科 眼科
- 干眼疾病研究 干眼疾病研究
- 梅博米腺功能障碍 治疗方法 治疗方法
背景情况:
- 梅腺功能障碍 (MGD) 是干眼疾病 (DED) 的主要原因.
- 传统的MGD治疗方法包括加热和表达.
- 最近的进展集中在针对MGD病理生理学的新疗法上.
研究的目的:
- 审查MGD当前和新型治疗策略.
- 讨论批准和新兴的药物和基于设备的MGD治疗方法.
- 突出MGD管理中的创新.
主要方法:
- 关于MGD治疗方法的文献搜索.
- 讨论常规,非药物和药物疗法.
- 对最近批准和正在研究的MGD治疗方法的分析.
主要成果:
- 了解MGD病理生理学使得有针对性的药物开发成为可能.
- 梅博是第一个FDA批准的药物,用于与MGD相关的DED,减少蒸发.
- AZR-MD-001显示为改善meibum的角质溶解和脂质生成剂的承诺.
结论:
- 向治疗是MGD治疗的重大进展.
- 新的治疗方法为眼睛表面疾病提供了更为定制的方法.
- 在MGD管理方面的创新正在改善患者的治疗结果.
相关概念视频
Open Angle Glaucoma: Treatment
391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
Direct-Acting Cholinergic Agonists: Therapeutic Uses
683
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
683
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Angle Closure Glaucoma: Treatment
434
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
434


